Evaluation of Wear Experience With PRECISION1® Contact Lenses in Previous Acuvue® Oasys® Lens Wearers
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ohio State University
- Enrollment
- 30
- Locations
- 2
- Primary Endpoint
- Contact Lens Dry Eye Questionnaire (CLDEQ-8) Survey
Study Overview
Brief Summary
To evaluate the wear experience of current two-week contact lens wearers after they have been fit into a daily disposable contact lens. This is a single arm, non-comparative study.
Detailed Description
This is a single arm, non-comparative study. All participants were habitual lens wearers of the same brand of lenses, and were re-fit with the study lenses.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Must be current Acuvue® Oasys® spherical contact lens wearers.
- •Distance visual acuity of 20/25 or better with current contact lenses.
- •Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI).
- •Ability to give informed consent.
- •Willing to spend time for the study, which includes attending two study visits and wearing contact lenses on days between study visits.
- •Either gender.
- •Any racial or ethnic origin.
Exclusion Criteria
- •No current ocular inflammation or infection.
- •Not currently pregnant or lactating.
Outcomes
Primary Outcomes
Contact Lens Dry Eye Questionnaire (CLDEQ-8) Survey
Time Frame: 2 weeks
Participants complete the Contact Lens Dry Eye Questionnaire (CLDEQ-8) survey. This is an 8 question survey assesses symptoms while wearing contact lenses with possible scores from 0 (no symptoms) to 37 (maximum symptoms). Higher scores indicate worsening symptoms of dry eye while wearing lenses.
Secondary Outcomes
No secondary outcomes reported
Investigators
Jennifer Fogt
Associate Professor Clinical
Ohio State University